Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 92


The biological function of long noncoding RNA FAL1 in oesophageal carcinoma cells.

Yang Z, Liu D, Wu D, Liu F, Liu C.

Artif Cells Nanomed Biotechnol. 2019 Dec;47(1):896-903. doi: 10.1080/21691401.2019.1573738.


Long Noncoding RNA FAL1 Promotes Cell Proliferation, Invasion and Epithelial-Mesenchymal Transition Through the PTEN/AKT Signaling Axis in Non-Small Cell Lung Cancer.

Pan C, Yao G, Liu B, Ma T, Xia Y, Wei K, Wang J, Xu J, Chen L, Chen Y.

Cell Physiol Biochem. 2017;43(1):339-352. doi: 10.1159/000480414. Epub 2017 Aug 31.


LncRNA FAL1 is a negative prognostic biomarker and exhibits pro-oncogenic function in osteosarcoma.

Wang Y, Zhao Z, Zhang S, Li Z, Li D, Yang S, Zhang H, Zeng X, Liu J.

J Cell Biochem. 2018 Nov;119(10):8481-8489. doi: 10.1002/jcb.27074. Epub 2018 Jul 10.


Long noncoding RNA FAL1 promotes proliferation and inhibits apoptosis of human colon cancer cells.

Wu K, Zhang N, Ma J, Huang J, Chen J, Wang L, Zhang J.

IUBMB Life. 2018 Nov;70(11):1093-1100. doi: 10.1002/iub.1880. Epub 2018 Oct 5.


Focally amplified lncRNA on chromosome 1 regulates apoptosis of esophageal cancer cells via DRP1 and mitochondrial dynamics.

Liu T, Wang Z, Zhou R, Liang W.

IUBMB Life. 2019 Feb;71(2):254-260. doi: 10.1002/iub.1971. Epub 2018 Nov 30.


Long non-coding RNA FAL1 functions as a ceRNA to antagonize the effect of miR-637 on the down-regulation of AKT1 in Hirschsprung's disease.

Li Y, Zhou L, Lu C, Shen Q, Su Y, Zhi Z, Wu F, Zhang H, Wen Z, Chen G, Li H, Xia Y, Tang W.

Cell Prolif. 2018 Oct;51(5):e12489. doi: 10.1111/cpr.12489. Epub 2018 Jul 30.


Long non-coding RNA FAL1 regulated cell proliferation through Akt pathway via targeting PDK1 in esophageal cancer cells.

Liang XS, Sun Y, Liu T.

Eur Rev Med Pharmacol Sci. 2018 Aug;22(16):5214-5222. doi: 10.26355/eurrev_201808_15719.


Relationship of Focally Amplified Long Noncoding on Chromosome 1 (FAL1) lncRNA with E2F Transcription Factors in Thyroid Cancer.

Jeong S, Lee J, Kim D, Seol MY, Lee WK, Jeong JJ, Nam KH, Jung SG, Shin DY, Lee EJ, Chung WY, Jo YS.

Medicine (Baltimore). 2016 Jan;95(4):e2592. doi: 10.1097/MD.0000000000002592.


LncRNA FAL1 promotes cell proliferation and migration by acting as a CeRNA of miR-1236 in hepatocellular carcinoma cells.

Li B, Mao R, Liu C, Zhang W, Tang Y, Guo Z.

Life Sci. 2018 Mar 15;197:122-129. doi: 10.1016/j.lfs.2018.02.006. Epub 2018 Feb 6.


Evaluation of prognostic usefulness of long noncoding RNA GAS5 and FAL1 in papillary thyroid carcinoma.

Shams F, Ghorbian S.

J Cell Biochem. 2019 Feb 11. doi: 10.1002/jcb.28425. [Epub ahead of print]


Oncogenic long noncoding RNA FAL1 in human cancer.

Zhong X, Hu X, Zhang L.

Mol Cell Oncol. 2015 Feb 25;2(2):e977154. doi: 10.4161/23723556.2014.977154. eCollection 2015 Apr-Jun.


Long non-coding RNA H1 promotes cell proliferation and invasion by acting as a ceRNA of miR‑138 and releasing EZH2 in oral squamous cell carcinoma.

Hong Y, He H, Sui W, Zhang J, Zhang S, Yang D.

Int J Oncol. 2018 Mar;52(3):901-912. doi: 10.3892/ijo.2018.4247. Epub 2018 Jan 16.


Highly expressed lncRNA FAL1 promotes the progression of gastric cancer by inhibiting PTEN.

Zhu CH, Xiao DH, Dai LG, Xu HG, Jiang YH, Zheng ZJ.

Eur Rev Med Pharmacol Sci. 2018 Dec;22(23):8257-8264. doi: 10.26355/eurrev_201812_16520.


LncRNA FAL1 promotes carcinogenesis by regulation of miR-637/NUPR1 pathway in colorectal cancer.

Wang L, Jiang F, Xia X, Zhang B.

Int J Biochem Cell Biol. 2019 Jan;106:46-56. doi: 10.1016/j.biocel.2018.09.015. Epub 2018 Sep 26.


Long non-coding RNA GHET1 promotes human breast cancer cell proliferation, invasion and migration via affecting epithelial mesenchymal transition.

Song R, Zhang J, Huang J, Hai T.

Cancer Biomark. 2018;22(3):565-573. doi: 10.3233/CBM-181250.


Long non-coding RNA HNF1A-AS1 regulates proliferation and migration in oesophageal adenocarcinoma cells.

Yang X, Song JH, Cheng Y, Wu W, Bhagat T, Yu Y, Abraham JM, Ibrahim S, Ravich W, Roland BC, Khashab M, Singh VK, Shin EJ, Yang X, Verma AK, Meltzer SJ, Mori Y.

Gut. 2014 Jun;63(6):881-90. doi: 10.1136/gutjnl-2013-305266. Epub 2013 Sep 2.


Long noncoding RNA RP11-766N7.4 functions as a tumor suppressor by regulating epithelial-mesenchymal transition in esophageal squamous cell carcinoma.

Yao GL, Pan CF, Xu H, Wei K, Liu B, Zhai R, Chen YJ.

Biomed Pharmacother. 2017 Apr;88:778-785. doi: 10.1016/j.biopha.2017.01.124. Epub 2017 Jan 31.


A functional genomic approach identifies FAL1 as an oncogenic long noncoding RNA that associates with BMI1 and represses p21 expression in cancer.

Hu X, Feng Y, Zhang D, Zhao SD, Hu Z, Greshock J, Zhang Y, Yang L, Zhong X, Wang LP, Jean S, Li C, Huang Q, Katsaros D, Montone KT, Tanyi JL, Lu Y, Boyd J, Nathanson KL, Li H, Mills GB, Zhang L.

Cancer Cell. 2014 Sep 8;26(3):344-357. doi: 10.1016/j.ccr.2014.07.009.


Long non-coding RNA XLOC_000647 suppresses progression of pancreatic cancer and decreases epithelial-mesenchymal transition-induced cell invasion by down-regulating NLRP3.

Hu H, Wang Y, Ding X, He Y, Lu Z, Wu P, Tian L, Yuan H, Liu D, Shi G, Xia T, Yin J, Cai B, Miao Y, Jiang K.

Mol Cancer. 2018 Jan 31;17(1):18. doi: 10.1186/s12943-018-0761-9.


Upregulation of the long non-coding RNA AFAP1-AS1 affects the proliferation, invasion and survival of tongue squamous cell carcinoma via the Wnt/β-catenin signaling pathway.

Wang ZY, Hu M, Dai MH, Xiong J, Zhang S, Wu HJ, Zhang SS, Gong ZJ.

Mol Cancer. 2018 Jan 8;17(1):3. doi: 10.1186/s12943-017-0752-2.

Supplemental Content

Support Center